Table 4

Latest year HbA1c adjusted* associations with HR-pQCT results

RadiusTibia
Coef. (95% CI)P valueCoef. (95% CI)P value
Bone strength
 Failure load, N−3.7 (−15.6 to 8.2)0.54−26.7 (−52.7 to −0.7)0.04
Geometry
 Total bone area, mm2−0.45 (−1.21 to 0.32)0.2−0.8 (−2.9 to 1.3)0.44
 Cortical area, mm20.02 (−0.20 to 0.24)0.87−0.22 (−0.56 to 0.13)0.21
 Tb area, mm2−0.46 (−1.25 to 0.31)0.25−0.58 (−2.68 to 1.52)0.58
Volumetric density
 Total vBMD, mg/cm30.12 (−1.27 to 1.51)0.86−0.77 (−1.69 to 0.15)0.10
 Cortical vBMD, mg/cm30.61 (−0.81 to 1.03)0.860.016 (−1.13 to 1.17)0.98
 Tb vBMD, mg/cm3−0.59 (−1.33 to 0.15)0.11−0.65 (−1.21 to −0.08)0.03
Microarchitecture
 Tb bone volume fraction−0.0005 (−0.001 to 0.000)0.11−0.0005 (−0.010 to −0.0001)0.03
 Tb thickness, mm−0.0000 (−0.0003 to 0.0002)0.79−0.0000 (−0.0003 to 0.0024)0.96
 Tb numbers, 1/mm−0.007 (−0.013 to −0.001)0.02−0.006 (−0.011 to −0.001)0.02
 Tb inhomogeneity0.002 (0.001 to 0.003)0.0050.001 (0.000 to 0.002)0.04
 Cortical thickness, mm0.001 (−0.004 to 0.006)0.59−0.019 (−0.007 to 0.003)0.43
 Cortical porosity, %−0.0001 (−0.0004 to 0.0003)0.56−0.0001 (−0.0006 to 0.0003)0.55
  • Statistical significance (p<0.05) is highlighted in bold.

  • *Adjusted for age, sex, height and body mass index.

  • HbA1c, glycated hemoglobin; HR-pQCT, high-resolution peripheral quantitative CT; Tb, trabecular bone; vBMD, volumetric bone mineral density.